157 related articles for article (PubMed ID: 30602499)
1. Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.
Yang B; Petrick JL; Thistle JE; Pinto LA; Kemp TJ; Tran HQ; Gewirtz AT; Waterboer T; Fedirko V; Jenab M; Graubard BI; Weinstein SJ; Albanes D; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):807-813. PubMed ID: 30602499
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
Petrick JL; Florio AA; Zen J; Wang Y; Gewirtz AT; Pfeiffer RM; Loftus S; Inglefield J; Koshiol J; Yang B; Yu K; Hildesheim A; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2023 Jul; 153(1):44-53. PubMed ID: 36878686
[TBL] [Abstract][Full Text] [Related]
3. Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
Fedirko V; Tran HQ; Gewirtz AT; Stepien M; Trichopoulou A; Aleksandrova K; Olsen A; Tjønneland A; Overvad K; Carbonnel F; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Boeing H; Bamia C; Lagiou P; Grioni S; Panico S; Palli D; Tumino R; Naccarati A; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Castaño JM; Barricarte A; Sánchez MJ; Dorronsoro M; Quirós JR; Agudo A; Sjöberg K; Ohlsson B; Hemmingsson O; Werner M; Bradbury KE; Khaw KT; Wareham N; Tsilidis KK; Aune D; Scalbert A; Romieu I; Riboli E; Jenab M
BMC Med; 2017 Apr; 15(1):72. PubMed ID: 28372583
[TBL] [Abstract][Full Text] [Related]
4. Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
Kong SY; Tran HQ; Gewirtz AT; McKeown-Eyssen G; Fedirko V; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bastide N; Affret A; Kühn T; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Kritikou M; Vasilopoulou E; Palli D; Krogh V; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Sala N; Sánchez MJ; Castaño JM; Barricarte A; Dorronsoro M; Werner M; Wareham NJ; Khaw KT; Bradbury KE; Freisling H; Stavropoulou F; Ferrari P; Gunter MJ; Cross AJ; Riboli E; Bruce WR; Jenab M
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):291-301. PubMed ID: 26823475
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
[TBL] [Abstract][Full Text] [Related]
7. Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.
Duarte-Salles T; Fedirko V; Stepien M; Trichopoulou A; Bamia C; Lagiou P; Lukanova A; Trepo E; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Racine A; Cadeau C; Kühn T; Aleksandrova K; Trichopoulos D; Tsiotas K; Boffetta P; Palli D; Pala V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Dik VK; Peeters PH; Weiderpass E; Torhild Gram I; Hjartåker A; Ramón Quirós J; Fonseca-Nunes A; Molina-Montes E; Dorronsoro M; Navarro Sanchez C; Barricarte A; Lindkvist B; Sonestedt E; Johansson I; Wennberg M; Khaw KT; Wareham N; Travis RC; Romieu I; Riboli E; Jenab M
Int J Cancer; 2014 Oct; 135(7):1662-72. PubMed ID: 24615266
[TBL] [Abstract][Full Text] [Related]
8. Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
Dhillon AK; Kummen M; Trøseid M; Åkra S; Liaskou E; Moum B; Vesterhus M; Karlsen TH; Seljeflot I; Hov JR
Liver Int; 2019 Feb; 39(2):371-381. PubMed ID: 30269440
[TBL] [Abstract][Full Text] [Related]
9. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut.
Maes M; Kubera M; Leunis JC; Berk M
J Affect Disord; 2012 Dec; 141(1):55-62. PubMed ID: 22410503
[TBL] [Abstract][Full Text] [Related]
10. Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.
Lai GY; Wang JB; Weinstein SJ; Parisi D; Horst RL; McGlynn KA; Männistö S; Albanes D; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1075-1082. PubMed ID: 29720370
[No Abstract] [Full Text] [Related]
11. Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China.
Du Y; Yu X; Chang ET; Lian S; Wu B; Li F; Chu B; Wei K; Zhan J; Liang X; Ye W; Ji M
BMC Cancer; 2023 Mar; 23(1):250. PubMed ID: 36922768
[TBL] [Abstract][Full Text] [Related]
12. Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present.
Simeonova D; Stoyanov D; Leunis JC; Carvalho AF; Kubera M; Murdjeva M; Maes M
Neurotox Res; 2020 Feb; 37(2):338-348. PubMed ID: 31802379
[TBL] [Abstract][Full Text] [Related]
13. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Sandler NG; Koh C; Roque A; Eccleston JL; Siegel RB; Demino M; Kleiner DE; Deeks SG; Liang TJ; Heller T; Douek DC
Gastroenterology; 2011 Oct; 141(4):1220-30, 1230.e1-3. PubMed ID: 21726511
[TBL] [Abstract][Full Text] [Related]
14. Circulating markers of microbial translocation and host response to bacteria with risk of colorectal cancer: a prospective, nested case-control study in men.
Shi M; Zong X; Hur J; Birmann BM; Martinez-Maza O; Epeldegui M; Chan AT; Giovannucci EL; Cao Y
EBioMedicine; 2023 May; 91():104566. PubMed ID: 37075493
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort.
Citronberg JS; Wilkens LR; Le Marchand L; Lim U; Monroe KR; Hullar MAJ; White E; Newcomb PA; Lampe JW
Cancer Causes Control; 2018 Jan; 29(1):115-123. PubMed ID: 29189972
[TBL] [Abstract][Full Text] [Related]
16. Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome.
Tian J; Hao L; Chandra P; Jones DP; Willams IR; Gewirtz AT; Ziegler TR
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G348-55. PubMed ID: 19095767
[TBL] [Abstract][Full Text] [Related]
17. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
[TBL] [Abstract][Full Text] [Related]
18. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
Ziegler TR; Luo M; Estívariz CF; Moore DA; Sitaraman SV; Hao L; Bazargan N; Klapproth JM; Tian J; Galloway JR; Leader LM; Jones DP; Gewirtz AT
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R402-10. PubMed ID: 18003793
[TBL] [Abstract][Full Text] [Related]
19. Tooth loss and liver cancer incidence in a Finnish cohort.
Yang B; Petrick JL; Abnet CC; Graubard BI; Murphy G; Weinstein SJ; Männistö S; Albanes D; McGlynn KA
Cancer Causes Control; 2017 Aug; 28(8):899-904. PubMed ID: 28534090
[TBL] [Abstract][Full Text] [Related]
20. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
